BioUtah will honor outstanding leaders in Utah’s life sciences community with five awards recognizing contributions to the industry.
PhotoPharmics Surpasses Enrollment Target with 350 Participants in First-of-a-Kind Remote, Home-Based Phase 3 “Light for PD” Clinical Trial
The target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) remain superior to percutaneous transluminal angioplasty (PTA) through 24 months
Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis
Company forms new AI business unit, led by Chief Technology & AI Officer Christopher Thurston, to unify and advance Co-Dx’s existing and future AI initiatives
Health insurance costs are projected to rise sharply in 2026
Co-Diagnostics Forms New AI Business Unit and Expands Global Footprint with CoMira Diagnostics
Earning the first-ever SGS Cybersecurity Mark in the baby monitor category, Owlet reinforces its leadership in safety, security, privacy, and innovation.
The new Saudi-based CoMira Diagnostics joint venture will be engaged in manufacturing and distribution of the Company’s upcoming Co-Dx™ PCR platform and other Co-Dx IP across KSA and 18 other MENA countries
SAPIEN 3, which showed superiority at 1 year, also demonstrates compelling outcomes equivalent to surgery at seven years
ENCIRCLE mitral trial achieves primary and secondary endpoints.
DiscGenics and Collaborators Announce Breakthrough in Tissue-Engineered Intervertebral Disc Research
As part of Governor Spencer Cox’s Australia Trade Mission from October 19–25, BioUtah led a focused Life Sciences Track highlighting Utah’s growing global leadership in biotechnology, medtech, diagnostics, and health innovation. The delegation met with prominent Australian partners, investors, and regulators to explore opportunities for collaboration and market expansion. Companies participating in the trade mission […]
Salt Lake City, Utah – October 21, 2025 Salt Lake City-based biotech firm Seek Labs announced today that it has expanded its Global Disease Atlas™ to include several of the world’s deadliest hemorrhagic fever viruses (HFVs) — namely, Ebola virus, Marburg virus, Lassa virus, Hantavirus, Crimean‑Congo hemorrhagic fever virus (CCHFV), and Rift Valley fever virus (RVFV). In July, the company announced that it […]
LEHI, Utah, Oct. 23, 2025 /PRNewswire/ — Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies that target the root causes of inflammation-driven diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its investigational medicine ofirnoflast (HT-6184) for the treatment of Myelodysplastic Syndromes (MDS) — a group […]
SALT LAKE CITY, October 21, 2025— ARUP Laboratories today announced the publication of an article in the Journal of Clinical Microbiology describing the company’s validation of a deep convolutional neural network (CNN) to detect parasites in concentrated wet mounts of stool. For decades, detection of gastrointestinal parasites has relied on traditional microscopy, which is a […]
SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced ceramics specializing in biomedical applications of silicon nitride (Si₃N₄), today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the SINAPTIC® Foot & Ankle Osteotomy Wedge System, enabling SINTX’s commercial entry […]
The Foresight® Carrier Screen includes all conditions recommended by the American College of Medical Genetics and Genomics recommendations
bioMérieux has just acquired a stake in Allergen Alert, an innovative startup specializing in the rapid detection of food allergens for individuals and professionals.
Asset acquisition would expand Merit’s Endoscopy portfolio with an innovative device to treat patients suffering from Barretts esophagus and other gastrointestinal disorders.
AI-powered voice analysis expands to detect verbal aggression and prevent nurse burnout through real-time vocal biomarker technology, enhancing clinician safety and patient care
Owlet expands its global footprint, entering one of the world’s most promising digital health markets, with CDSCO-approved technology.
AGREEMENT INCLUDES ACTINIUM-225 (AC-225) AND LUTETIUM-177 (LU-177) TO SUPPORT ARICEUM’S THERAPEUTIC PROGRAMS
In-vitro studies confirm that the Company’s novel Smart mRNA could drastically reduce off-target liver toxicity, a major issue affecting many cancer drugs
Halia Therapeutics Expands to Abu Dhabi
Leash Bio Announces Multi-Target Agreement with Monte Rosa Therapeutics
SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care.
Attendees invited to Booth #732 for pivotal trial updates and to discuss unmet needs in Parkinson’s care.
Halia Therapeutics Named as 2025 Top 10 Longevity Breakthrough Award Winner
BioSeeker mapped more than 10,000 isolates and identified targetable regions that provide 100% strain coverage across the viral family.
Biolexis Therapeutics Initiates First-in-Human Clinical Trials for Novel, Oral Muscle-Sparing, Weight Loss and Type 2 Diabetes Therapies
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5
